Dupixent (dupilumab) - Sanofi, Regeneron
Allergic Laryngitis with Dysphonia Responding to Dupilumab (ACAAI 2026) - Oct 28, 2026 - Abstract #R366; Pres time: Nov 15, 2026; 12:15 PM - 01:00 PM; Location: Phoenix Convention Center • North Halls 4–6 (Lower Level); Monitor 24; No abstract available 
Dysphonia • Otorhinolaryngology
https://annualmeeting.acaai.org/2026/submit_abstract.cfm
 
Oct 28, 2026
 
Prev Next